Boston Therapeutics, Inc. Uncategorized Contracts & Agreements

18 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Securities of Nanomix Corporation
Boston Therapeutics, Inc.
Pharmaceuticals
2023
Offer Letter for Chris Hetterly, dated November 15, 2022
Boston Therapeutics, Inc.
Pharmaceuticals
2023
Offer Letter, dated July 21, 2022
Boston Therapeutics, Inc.
Pharmaceuticals
2022
Offer Letter, dated February 28, 2022
Boston Therapeutics, Inc.
Pharmaceuticals
2022
Description of Securities of Nanomix Corporation
Boston Therapeutics, Inc.
Pharmaceuticals
2022
Unwind Agreement between Boston Therapeutics, Inc., Cure DM, Inc. and Cure DM Group Holdings, LLC signed August 6, 2019
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2019
Certificate of Designation dated August 14, 2017
Boston Therapeutics, Inc.
Pharmaceuticals
DE
2017
Letter Agreement dated March 27, 2017 entered between Boston Therapeutics, Inc. and Carl W. Rausch
Boston Therapeutics, Inc.
Pharmaceuticals
2017
Letter Agreement between the Company and CJY Holdings Limited dated August 12, 2016
Boston Therapeutics, Inc.
Pharmaceuticals
2016
Form of 6% Senior Convertible Debuenture
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2016
Letter Amendment by and between Boston Therapeutics, Inc. and CJY Holdings Limited dated June 28, 2016
Boston Therapeutics, Inc.
Pharmaceuticals
2016
Letter Amendment by and between Boston Therapeutics, Inc. and CJY Holdings Limited dated May 6, 2016
Boston Therapeutics, Inc.
Pharmaceuticals
2016
Letter Amendment by and between Boston Therapeutics, Inc. and CJY Holdings Limited dated March 11, 2016
Boston Therapeutics, Inc.
Pharmaceuticals
2016
Letter Amendment by and between Boston Therapeutics, Inc. and CJY Holdings Limited dated March 1, 2016
Boston Therapeutics, Inc.
Pharmaceuticals
2016
Letter Amendment by and between Boston Therapeutics, Inc. and CJY Holdings Limited dated November 30, 2015
Boston Therapeutics, Inc.
Pharmaceuticals
2015
Letter Amendment by and between Boston Therapeutics, Inc. and CJY Holdings Limited
Boston Therapeutics, Inc.
Pharmaceuticals
2015
Letter Agreement by and between Boston Therapeutics, Inc. and Typenex Co-Investment, LLC
Boston Therapeutics, Inc.
Pharmaceuticals
2015
Boston Therapeutics, Inc. OTCQB:BTHE1750 Elm Street Suite 103Manchester, NH03104Tel: (603) 935-9799Fax: (603) 685-4784www.bostonti.com
Boston Therapeutics, Inc.
Pharmaceuticals
2012